Apoptotic threshold is lowered by p53 transactivation of caspase-6

被引:129
作者
MacLachan, TK
El-Deiry, WS [1 ]
机构
[1] Univ Penn, Sch Med, Howard Hughes Med Inst, Lab Mol Oncol & Cell Cycle Regulat, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
[5] Univ Penn, Sch Med, Ctr Canc, Philadelphia, PA 19104 USA
关键词
chemosensitivity; apoptosis; transcription; tumor suppressor; lamin A;
D O I
10.1073/pnas.132241599
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Little is known about how a cell's apoptotic threshold is controlled after exposure to chemotherapy, although the p53 tumor suppressor has been implicated. We identified executioner caspase-6 as a transcriptional target of p53. The mechanism involves DNA binding by p53 to the third intron of the caspase-6 gene and transactivation. A p53-dependent increase in procaspase-6 protein level allows for an increase in caspase-6 activity and caspase-6-specific Lamin A cleavage in response to Adriamycin exposure. Specific inhibition of caspase-6 blocks cell death in a manner that correlates with caspase-6 mRNA induction by p53 and enhances long-term survival in response to a p53-mediated apoptotic signal. Caspase-6 is an executioner caspase found directly regulated by p53, and the most downstream component of the death pathway controlled by p53. The induction of caspase-6 expression lowers the cell death threshold in response to apoptotic signals that activate caspase-6. Our results provide a potential mechanism of lowering the death threshold, which could be important for chemosensitization.
引用
收藏
页码:9492 / 9497
页数:6
相关论文
共 34 条
[1]   Human ICE/CED-3 protease nomenclature [J].
Alnemri, ES ;
Livingston, DJ ;
Nicholson, DW ;
Salvesen, G ;
Thornberry, NA ;
Wong, WW ;
Yuan, JY .
CELL, 1996, 87 (02) :171-171
[2]   Proteases to die for [J].
Cryns, V ;
Yuan, JY .
GENES & DEVELOPMENT, 1998, 12 (11) :1551-1570
[3]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[4]   SATB1 cleavage by caspase 6 disrupts PDZ domain-mediated dimerization, causing detachment from chromatin early in T-cell apoptosis [J].
Galande, S ;
Dickinson, LA ;
Mian, IS ;
Sikorska, M ;
Kohwi-Shigematsu, T .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (16) :5591-5604
[5]   Inhibition of human caspases by peptide-based and macromolecular inhibitors [J].
Garcia-Calvo, M ;
Peterson, EP ;
Leiting, B ;
Ruel, R ;
Nicholson, DW ;
Thornberry, NA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) :32608-32613
[6]   Direct transcriptional activation of human caspase-1 by tumor suppressor p53 [J].
Gupta, S ;
Radha, V ;
Furukawa, Y ;
Swarup, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (14) :10585-10588
[7]   Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis [J].
Hirata, H ;
Takahashi, A ;
Kobayashi, S ;
Yonehara, S ;
Sawai, H ;
Okazaki, T ;
Yamamoto, K ;
Sasada, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (04) :587-600
[8]  
Komata T, 2001, CANCER RES, V61, P5796
[9]   Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease [J].
LeBlanc, A ;
Liu, H ;
Goodyer, C ;
Bergeron, C ;
Hammond, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) :23426-23436
[10]   P53 STATUS AND THE EFFICACY OF CANCER-THERAPY IN-VIVO [J].
LOWE, SW ;
BODIS, S ;
MCCLATCHEY, A ;
REMINGTON, L ;
RULEY, HE ;
FISHER, DE ;
HOUSMAN, DE ;
JACKS, T .
SCIENCE, 1994, 266 (5186) :807-810